Physical Therapists in Dover, DE Accepting Medicare
129 Physical Therapists found. Showing 121 - 129
 Jason Thomas Berg, MSPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1125 Forrest Ave Ste 101, Dover, DE 19904 Phone: 302-735-4900 Fax: 302-735-4900 |
 Ashley Christine Ulrich Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 285 Beiser Blvd Ste 202, Dover, DE 19904 Phone: 302-747-5995 |
Nicki Dixon, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 642 S Queen St, Suite 102, Dover, DE 19904 Phone: 302-674-1269 Fax: 302-674-1749 |
Ms. Mary Mundrane, MPT,ATC,CHT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 230 Beiser Blvd, Suite 103, Dover, DE 19904 Phone: 302-736-0994 Fax: 302-736-5529 |
 Phoenix Rehabilitation And Health Services Of Delaware Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 230 Beiser Blvd Ste 103, Dover, DE 19904 Phone: 302-672-0293 |
Michael Walsh, PT Physical Therapist - Orthopedic Medicare: Accepting Medicare Assignments Practice Location: 1675 S State St, Suite A, Dover, DE 19901 Phone: 302-632-9180 |
Jessica Clausen, PT, DPT, ATC Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1255 S State St, Suite 7, Dover, DE 19901 Phone: 302-734-0100 Fax: 302-734-0101 |
Dr. Nicholas Bojda, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 551 S Red Haven Ln Ste 102, Dover, DE 19901 Phone: 302-697-4294 |
Mrs. Cindy L Burritt, PTA Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1080 Silver Lake Blvd, Dover, DE 19904 Phone: 302-734-5990 |
News Archive
Economists, Dems differ on who's to blame for insurers' rate hikes
Democrats assailed health insurers for hiking rates in recent weeks to gain popular momentum for their health overhaul, but health economists say insurers did cause high health costs, the Milwaukee Journal Sentinel reports. The economists "contend that insurance companies, while often meriting criticism for their practices, aren't to blame for high health care costs."
Drastic market changes with MRI contrast media and PET radiopharmaceuticals emerging as most promising segments
Significant changes in the European contrast media and radiopharmaceuticals market are seeing some segments experience growth while others near saturation.
Anti-SARS-CoV-2 drug candidate enters phase I clinical trial
DC402234 (FB2001), an anti-SARS-CoV-2 drug candidate mainly developed by research team at the Shanghai Institute of Materia Medica (SIMM) of Chinese Academy of Sciences enters its Phase I clinical trial in the United States on March 15.
ADVENTRX' ANX-530 NDA: FDA issues refuse to file letter
ADVENTRX Pharmaceuticals, Inc. announced today that it received a refuse to file letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ANX-530 (vinorelbine injectable emulsion). In the letter, the FDA indicated that the data included in the initial submission from the intended commercial manufacturing site was insufficient to support a commercially-viable expiration dating period. FDA identified only the one chemistry, manufacturing and controls (CMC) reason for the refusal to file. ADVENTRX plans to meet with the FDA as soon as possible to discuss its response.
› Verified 2 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Occupational Therapists
Podiatrists
Audiologists